CoreCap Advisors’s Zivo Bioscience ZIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13.2K Hold
4,360
– – ﹤0.01% 1974
2026
Q2
$17.6K Hold
4,360
– – ﹤0.01% 1853
2026
Q1
$29.4K Hold
4,360
– – ﹤0.01% 1518
2025
Q4
$37.9K Hold
4,360
– – ﹤0.01% 1432
2025
Q3
$56.7K Hold
4,360
– – ﹤0.01% 1265
2025
Q2
$58.9K Buy
+4,360
New +$58.9K ﹤0.01% 1183

CoreCap Advisors's ZIVO Position: Q3 2026 in Review

CoreCap Advisors held its Zivo Bioscience (ZIVO) position steady in Q3 2026 at 4,360 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1974.

CoreCap Advisors first reported a position in ZIVO in Q2 2025 and has held it in 6 quarters since. The position peaked at $58.9K in Q2 2025. 1 fund tracked by Wall St. Rank holds ZIVO as of Q3 2026.

  • CoreCap Advisors held 4,360 shares of Zivo Bioscience worth $13.2K as of Q3 2026.
  • CoreCap Advisors left its Zivo Bioscience share count unchanged in Q3 2026.
  • Zivo Bioscience made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #1974 holding.
  • CoreCap Advisors first reported a position in Zivo Bioscience in Q2 2025 and has held it in 6 quarters since.
  • CoreCap Advisors's Zivo Bioscience position peaked at $58.9K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held Zivo Bioscience as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.